ABSTRACT
Split Hand/Foot Malformation (SHFM) is a rare limb abnormality with clefting of the fingers and/or toes. For many patients, the genetic etiology is unknown. Through whole exome and targeted sequencing, we detected three novel variants in a transcription factor, PRDM1 that arose de novo in families with SHFM or segregated with the phenotype. PRDM1 is required for limb development; however, its role is not well understood, and it is unclear how the PRDM1 variants affect protein function. Using transient and stable overexpression rescue experiments in zebrafish, we show that the variants, which disrupt the proline/serine-rich and DNA-binding zinc finger domains have reduced function compared to wildtype PRDM1. Through gene expression assays, RNA-seq, and CUT&RUN in isolated pectoral fin cells, we demonstrate that Prdm1a directly binds to and regulates genes required for limb induction, outgrowth, and anterior/posterior patterning, such as fgfr1a, dlx5a, dlx6a, and smo. Together, these results improve our understanding of the role of PRDM1 in the limb gene regulatory network and demonstrate the pathogenicity of PRDM1 variants in humans.
SUMMARY STATEMENT PRDM1 proline/serine and zinc finger domains are required to regulate limb induction, outgrowth, and anterior/posterior patterning. Variants in PRDM1 are shown to cause Split Hand/Foot Malformation in humans.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
NIH
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Greenwood Genetics Center, Self Regional Healthcare IRB approval for Molecular Studies of Split-Hand/Split-foot Malformations IRB#33
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Data Availability
Sequencing data available via GEO.
https://nam02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fgeo%2Fquery%2Facc.cgi%3Facc%3DGSE217486&data=05%7C01%7Cbrittany.truong%40cuanschutz.edu%7Cb0b16ce4fac545bd05c308dac0ff6b58%7C563337caa517421aaae01aa5b414fd7f%7C0%7C0%7C638034500518463277%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=G3o50sLtqbV2ViSZHH%2FZCazdjkJ2%2FaFsn1TjWMp93nw%3D&reserved=0